Postgraduate Course – Paradigm Shifts In Hepatology: Rethinking Conventional Wisdom

Part I: 8:00 am – Noon | Part II: 1:30 pm – 4:30 pm | Audience Q&A: 4:30 pm – 5:30 pm

Program Chairs: Raymond T. Chung, MD, FAASLD; Kimberly A. Brown, MD, FAASLD; Lawrence S. Friedman, MD, FAASLD

The practice of hepatology has undergone profound shifts driven by new pathophysiologic insights which, in many cases, force us to rethink traditional medical dogma. This is also an era of profound progress in diagnostics and therapeutics. This program explores these seismic shifts to allow attendees to re-energize their practices, and embrace new goals and objectives for treating many liver diseases.

‍

Program Agenda

Part I

8:00 am - noon

Session I: The Changing Practice of Hepatology

• The Evolution of Personalized Medicine in Hepatology Practice
• Toward a Biopsy Free World
• Care of Patients with Advanced Liver Disease: A Team Sport
• Measuring the Unmeasurable: Incorporating Quality Metrics into the Care of Patients with Cirrhosis
• Virtual Care: The Future is Now

Session II: New Concepts in Metabolic and Toxic Liver Disease

• NAFLD Beyond Obesity
• Rethinking Management of Alcohol-associated Liver Disease: The Other Fatty Liver Epidemic
• The Gut-Liver Axis: What the Clinician Needs to Know

Session III: The Immune System and the Liver

• Evolving Management of Autoimmune Liver Disease: Beyond Conventional Immunosuppression
• Liver Disease Related to Cancer Immunotherapy
• DILI as an Immune Disorder of the Liver: Implications for Management

Learning Objectives:

• Identify important conceptual changes that have altered our management of liver diseases.
• Apply insights from pathophysiology to selection of new treatments for patients with liver diseases.
• Apply new standards regarding quality of care to their practice of hepatology.

Part II

1:30 pm - 4:30 pm

Session IV: Rethinking Complications of Liver Disease

• Acute-on-Chronic Liver Failure: Evolving Concepts
• Portal Hypertension: Revisiting our Principles
• Hemostasis and Thrombosis in Chronic Liver Disease: New Concepts in Management
• Evolving Strategies to Optimize Outcome in Liver Transplantation
• Transformation of the HCC Management Paradigm

Session V: Revising Our Goals in Viral Hepatitis

• Hepatitis C: Cure, Yes, but We’re Not Done Yet
• HBV and HDV: Can We Now Talk About Cure?
• Other Viruses Affecting the Liver, including SARS-CoV-2

Learning Objectives:

• Identify important conceptual changes that have altered our management of liver diseases.
• Apply insights from pathophysiology to selection of new treatments for patients with liver diseases.
• Apply new standards regarding quality of care to their practice of hepatology.
  

Audience Q&A

4:30 pm - 5:30 pm

Live! Not available on demand.

‍

‍